Page last updated: 2024-11-05

dimedone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dimedone, also known as 5,5-dimethyl-1,3-cyclohexanedione, is a cyclic β-diketone that serves as a versatile building block in organic synthesis. It is commonly synthesized through a multi-step process involving the condensation of acetone with diethyl malonate. Dimedone exhibits diverse biological activities including anti-inflammatory, antioxidant, and antimicrobial properties. Its ability to chelate metal ions has led to its use in various applications such as metal extraction, catalysis, and sensor development. The unique reactivity of dimedone, attributed to its enolizable character, makes it a valuable reagent for various reactions like aldol condensations, Michael additions, and Diels-Alder reactions. Dimedone's synthetic versatility and potential biological applications have made it a subject of extensive research, particularly in the areas of medicinal chemistry and materials science.'

dimedone: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31358
SCHEMBL ID123127
MeSH IDM0045926

Synonyms (71)

Synonym
1, 5,5-dimethyl-
5,5-dimethyl-1,3-cyclohexanedione
nsc43759
nsc-43759
nsc242994
nsc-242994
nsc 14984
ai3-19939
einecs 204-804-4
1,1-dimethyl-3,5-diketocyclohexane
1,1-dimethyl-3,5-cyclohexanedione
1,5-cyclohexanedione
lu 274
cyclomethone
5,5-dimethyldihydroresorcinol
nsc14984
5,5-dimethylhydroresorcinol
dimedon
dimedone
nsc-14984
126-81-8
medon
5,3-cyclohexanedione
nsc17544
methon
nsc-17544
methone
1,5-diketocyclohexane
5,3-dione
5,5-dimethylcyclohexane-1,3-dione
1,3-cyclohexanedione, 5,5-dimethyl-
inchi=1/c8h12o2/c1-8(2)4-6(9)3-7(10)5-8/h3-5h2,1-2h
STK365156
5,5-dimethyl-1,3-cyclohexanedione, 95%
D0701
AKOS000119900
A805613
unii-b2b5dsx2fc
b2b5dsx2fc ,
ec 204-804-4
5,5-dimethyl-cyclohexane-1,3-dione
dimethyldihydroresorcinol
BP-12997
FT-0625018
5,5-dimethyl-1,3-cyclohexanedione [mi]
5, 5-dimethyl-1,3-cyclohexanedione
5,5-dimethylcyclohexan-1,3-dione
5,5-dimethyl-1,3-cyclohexandione
5,5-dimethyl-1, 3-cyclohexanedione
5,5-dimethyl-1,3-cyclohexandion
5,5-dimethyl-1,3cyclohexanedione
SCHEMBL123127
Q-200991
5,5-dimethyl-1,3-cyclohexadione
5,5-dimethyl-1,3-dihydroresorcinol
5,5'-dimethylcyclohexane-1,3-dione
mfcd00001588
DTXSID8021987
F0001-0386
5,5-dimethyl-1,3-cyclohexanedione, for hplc derivatization, for the determination of aldehyde formaldehyde, >=99.0%
SY010547
Q418261
CS-W016456
AS-14592
AM10627
SB15818
2,2 dimethyl,1,6 cyclohexa dione; dimedone
D70508
EN300-19675
HY-W015740
Z104474686

Research Excerpts

Effects

Dedone has been introduced as a new chemical compound with anti-bacterial and anti-cancer properties. The dimedone adduct has been characterized by mass spectrometry (MS) and (1)H and (13)C NMR spectroscopy.

ExcerptReferenceRelevance
"Dimedone (DIM) has been introduced as a new chemical compound with anti-bacterial and anti-cancer properties."( Dimedone nanoparticle as a promising approach against toxoplasmosis: In vitro and in vivo evaluation.
Asl, SS; Barati, N; Fallah, M; Farmani, A; Foroughi-Parvar, F; Maghsood, AH; Motavallihaghi, S; Nematollahi, D, 2023
)
3.07
"The dimedone adduct has been characterized by mass spectrometry (MS) and (1)H and (13)C NMR spectroscopy."( Formation and fate of a sulfenic acid intermediate in the metabolic activation of the antithrombotic prodrug prasugrel.
Bertho, G; Dansette, PM; Mansuy, D; Thébault, S, 2010
)
0.84

Treatment

ExcerptReferenceRelevance
"Pretreatment with dimedone to alter S-sulfenylation function or with Src kinase inhibitors inhibited FN-f-induced production of matrix metalloproteinase 13."( Cysteine-Mediated Redox Regulation of Cell Signaling in Chondrocytes Stimulated With Fibronectin Fragments.
Burke, EA; Furdui, CM; Klomsiri, C; Loeser, RF; Long, DL; Poole, LB; Reisz, JA; Wood, ST; Yammani, RR, 2016
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (5.26)18.7374
1990's5 (6.58)18.2507
2000's15 (19.74)29.6817
2010's39 (51.32)24.3611
2020's13 (17.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.10 (24.57)
Research Supply Index4.41 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index81.04 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (6.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other76 (93.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]